Health Care after the Election image

October 24, 2016 12:00 PM
Lectures and Panels
2016-2017
Wasserstein Hall, Milstein West AB (2019)
Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA

VIDEO: Introduction, Gregory Curfman, Harvard Health Publications
VIDEO: Panel Discussion: Joseph Antos, Chris Jennings, and I. Glenn Cohen
VIDEO: Audience Q & A

Looking for more on this topic now that the election has been decided? Check out our 5th Annual Health Law Year in P/Review on January 23, 2017. At this full-day event, we will discuss major developments during 2016 and what to watch out for in 2017. The event will begin with a panel of leading experts addressing the topic "The End of ObamaCare? Health Care Reform Under A New Administration." Learn more and register now on the conference website!

Description:

As we approached the 2016 presidential election and change of administration, there were many questions about the future of health policy that the 45th President and Congress will have to address starting in 2017. This event brought together health care experts from both sides of the aisle to discuss what health care will - and should - look like under the next administration. 

Topics discussed included: 

  • The Affordable Care Act

  • Drug pricing

  • Delivery system reform

  • Innovation and research funding/NIH

  • Mental health

  • Public health

Speakers

  • Opening Remarks: Gregory Curfman, Editor in Chief, Harvard Health Publications, Harvard Medical School

  • Joseph R. Antos, PhD, Wilson H. Taylor Scholar in Health Care and Retirement Policy, American Enterprise Institute

  • Chris Jennings, Founder and President, Jennings Policy Strategies, Inc.

  • Moderator: I. Glenn Cohen, Professor of Law, Harvard Law School and Faculty Director, Petrie-Flom Center

Learn More

NEJM Editors' Note: The editors invited the Democratic and Republican presidential nominees, Hillary Clinton and Donald Trump, to answer the following question for Journal readers: What specific changes in policy do you support to improve access to care, improve quality of care, and control health care costs for our nation? Secretary Clinton responded. Mr. Trump did not respond.

This event was free and open to the public.

Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund.

Videos

VIDEO: Introduction, Gregory Curfman, Harvard Health Publications
VIDEO: Panel Discussion: Joseph Antos, Chris Jennings, and I. Glenn Cohen
VIDEO: Audience Q & A

Tags

addiction   fda   health care finance   health care reform   health law policy   innovation   judicial opinions   medicaremedicaid   mental health   pharmaceuticals   public health   regulation